Core Viewpoint - Linuo Pharmaceutical has successfully developed and implemented an automated production line for borosilicate glass tubes, achieving self-controlled and large-scale production, which addresses the long-standing reliance on imports for critical pharmaceutical packaging materials [1][4]. Group 1: Production Technology - The company has established a new borosilicate glass melting furnace in 2022, overcoming technical bottlenecks in the melting process [1]. - The production process utilizes an automated batching control system that ensures 100% uniformity in raw material mixing, significantly reducing glass defects [3]. - The melting furnace employs a DCS control system with full oxygen combustion and electric assistance, optimizing the melting efficiency and quality of the glass [3]. Group 2: Quality Control - The production line incorporates advanced technologies such as platinum technology for precise temperature control, ensuring uniform flow and stable thermal properties of the molten glass [3]. - Automated online inspection systems are in place for real-time monitoring of glass tube dimensions and quality, ensuring that defective products do not reach the market [3][4]. Group 3: Automation and Innovation - The company has developed an automatic cutting and sealing machine for glass tubes, which minimizes contamination during post-processing [4]. - Automated stacking and packaging processes are implemented to enhance cleanliness and reduce the risk of damage, utilizing AGV systems for transportation [4]. - Linuo Pharmaceutical's focus on innovation and automation has led to a complete intelligent production line for borosilicate glass tubes, promoting high-quality domestic alternatives in the pharmaceutical packaging sector [4].